The Europe sleep apnea devices market is expected to reach US$ 2,804.7 Mn in 2025 from US$ 1,515.5 Mn in 2017. The market is estimated to grow with a CAGR of 8.3% from 2018-2025. The growth of the market is driven by the factors such as, increased patient base of sleep apnea and availability of technologically advanced diagnostic & therapeutic devices. However, the market is likely to get impacted due to risks associated with sleep apnea in the region.The prevalence of sleep disorders has been increasing in Europe. As a result, the sleep centers are expanding in the hospitals and private care environment to meet the demands. However, the number of sleep centers and caregivers in the region is not sufficient. Many sleep disorders are chronic and require continuous treatment and monitoring of therapy success. Thus, the cost-efficient technologies for the initial diagnosis and for follow-up monitoring of treatment are important. Many new advanced methods for recording sleep and diagnosing sleep disorders have been developed. For instance, wireless recording of sleep and related biosignals allows diagnostic tools and therapy follow-ups.In order for a better understanding of the pathophysiology of sleep disorders, sleep research requires new technologies to investigate underlying mechanisms in the regulation of sleep. Home recording and non-obtrusive recording over extended periods of time with telemedicine methods support this research. In addition, growing advances in techniques comprise development and application of portable equipment. For instance, these portable equipment allows HSAT (Home sleep apnea testing) systems that allow patients to enter sleep times manually. This will further allow the assessment software to adjust the calculation of directories of respiratory events for corrected sleep duration. Some other systems assess sleep times indirectly by an additional light or activity monitoring. All of these portable systems are called HSAT or polygraphy (PG) in Europe. Owing to the above mentioned factors, the sleep apnea market is anticipated to significantly grow in the region.Germany is expected to lead the market in the Europe region owing to focus on research and development activities and availability of funds for research are the important factors. Moreover, increasing awareness about screening of selected risk groups for sleep apnea, its diagnosis and treatment and availability of healthcare centers drive the market growth during the forecast period. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the Europe region during the forecast period. Germany Sleep Apnea Devices Market Revenue and Forecasts to 2025 (US$ Mn)
• Polysomnography Devices
• Respiratory Polygraphs
• Actigraphy systems
• Oximeters
By Therapeutic Devices • Facial Interfaces
• Adaptive Servo-Ventilation Instruments (ASV)
• Positive Airway Pressure (PAP) Devices
• Oxygen Concentrators
• Airway Clearance Systems
• Oral Appliances
• Accessories
By End User• Home Healthcare
• Sleep Laboratories and Hospitals
By Geography• Europe
• Germany
• France
• UK
Company Profiles• RedMed
• Koninklijke Philips N.V.
• Braebon Medical Corporation
• Compumedics Limited
• BMC Medical Co., Ltd.
• Fisher & Paykel Healthcare Limited.
• SomnoMed Limited
• Weinmann Emergency Medical Technology GmbH CO. KG
• Devilbiss Healthcare LLC.
• Whole You, Inc.